Cardiac Monitoring & Cardiac Rhythm Management Devices Market Size, Value, Outlook, Growth, Trends and 2024 Forecast Analysis

(The Express Wire via Comtex)

ReportsnReports released a new research report of 165 pages on title 'Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market Insights by Application, Product Type, Competitive Landscape & Regional Forecast 2024' with detailed analysis, forecast and strategies.

2019 Research Report on Global Cardiac Monitoring and Cardiac Rhythm Management Devices Market is a professional and comprehensive report on the Cardiac Monitoring and Cardiac Rhythm Management Devices industry.

#Download Free PDF Sample Brochure of report Global Cardiac Monitoring and Cardiac Rhythm Management Devices Market 2019 across with 165 Pages and in-depth TOC Analysis @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=218817

Key Players: Medtronic (Ireland), Boston Scientific (US), Abbott Laboratories (US), GE Healthcare (US), BIOTRONIK (Germany), Hill-Rom Holdings (US), and Koninklijke Philips (Netherlands). The study includes an in-depth competitive analysis of these key players in the CM and CRM devices market, along with their company profiles, recent developments, and key market strategies.

“Increasing prevalence of CVD to drive the growth of this market.”

The cardiac monitoring and cardiac rhythm management devices market is projected to reach USD 25.0 billion by 2024 from USD 20.7 billion in 2019, at a CAGR of 3.9%. Growth in this market is primarily driven by the increasing incidence of cardiovascular diseases; technological advancements; increasing investments, funds, and grants for research on CM and CRM devices; and the growing preference for wearable cardiac devices. However, the dearth of skilled professionals and frequent product recalls are expected to challenge market growth in the coming years

“ILRs are expected to grow at the highest CAGR during the forecast period.”

Based on type, the CM devices market is segmented into ECG devices, ILR, MCT, event monitors, COM devices, and smart ECG monitors. Of these, ILRs are expected to grow at the highest CAGR during the forecast period. The advantages of ILRs are a higher rate of diagnosis of heart rhythm problems than external recorders, long-term monitoring of up to three years, large storage capacity, remote monitoring, and detection and reduction of recurrent syncopes. Owing to their benefits, the demand for these devices is expected to increase across the globe

“The defibrillators segment is expected to grow at the highest CAGR during the forecast period.”

Based on type, the CRM devices market is segmented into defibrillators and pacemakers. The defibrillators segment is expected to grow at the highest CAGR in the forecast period. Technological advancements in defibrillators, rising prevalence of CVDs, and the growing focus on providing public-access defibrillators are some of the major factors expected to propel the growth of this market.

Get Flat 20% Discount on this Latest Research Report @ https://www.reportsnreports.com/contacts/discount.aspx?name=218817

“The ambulatory surgical centers segment is expected to grow at the highest CAGR during the forecast period.”

The ambulatory surgical centers segment is expected to grow at the highest CAGR in the forecast period. Growing number of ASCs and physicians are realizing the benefits of performing cardiovascular procedures at ASCs, thus attributing to its high CAGR during the forecast period.

“APAC to grow at the highest CAGR during the forecast period.”

In the CM and CRM devices market, the APAC market, particularly in China, Japan, India, and the Association of Southeast Asian Nations (ASEAN) countries, is expected to witness the highest growth in the next five years. This is due to the rising prevalence of CVDs in APAC countries, attributed to the increasing adoption of sedentary lifestyles, changing diets, increasing stress, and habitual smoking and drinking.

In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the CM and CRM devices market.

  • By Company Type: Tier 1:40%, Tier 2: 30%, and Tier 3: 30%
  • By Designation: C-level Executives: 27%, Directors: 18%, and Others:55%
  • By Region: North America: 50%, Europe: 20%, APAC: 15%, and RoW: 15%

Research Coverage: The market study covers the CM and CRM devices market across various segments. It aims at estimating the market size and the growth potential of this market across different segments, based on CM devices by type, and based on CRM devices by type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Download Free Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=218817

In the end, the Global Cardiac Monitoring and Cardiac Rhythm Management Devices Market report’s conclusion part notes the estimation of the industry veterans.

Connect Us for more information at [email protected] or Call Us + 1 888 391 5441.

About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers and in-depth market research studies of over 5000 micro markets.

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Cardiac Monitoring & Cardiac Rhythm Management Devices Market Size, Value, Outlook, Growth, Trends and 2024 Forecast Analysis